These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 23891641)

  • 21. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in Alzheimer's disease drug discovery: an update.
    Williams M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current perspectives on pharmacotherapy of Alzheimer's disease.
    Chopra K; Misra S; Kuhad A
    Expert Opin Pharmacother; 2011 Feb; 12(3):335-50. PubMed ID: 21222549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model.
    Paban V; Manrique C; Filali M; Maunoir-Regimbal S; Fauvelle F; Alescio-Lautier B
    Neuropharmacology; 2014 Jan; 76 Pt A():68-79. PubMed ID: 23891615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012).
    Belluti F; Rampa A; Gobbi S; Bisi A
    Expert Opin Ther Pat; 2013 May; 23(5):581-96. PubMed ID: 23425062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease modifying therapy for AD?
    Golde TE
    J Neurochem; 2006 Nov; 99(3):689-707. PubMed ID: 17076654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs for treatment of Alzheimer's disease.
    Wilkinson D
    Int J Clin Pract; 2001 Mar; 55(2):129-34. PubMed ID: 11321852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
    Francis PT; Nordberg A; Arnold SE
    Trends Pharmacol Sci; 2005 Feb; 26(2):104-11. PubMed ID: 15681028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
    León R; Garcia AG; Marco-Contelles J
    Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-cholinergic pharmacotherapy approaches to the future treatment of Alzheimer's disease.
    Castro A; Conde S; Rodriguez-Franco MI; Martinez A
    Mini Rev Med Chem; 2002 Feb; 2(1):37-50. PubMed ID: 12369956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
    Gasparini L; Ongini E; Wenk G
    J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes.
    Bak AM; Egefjord L; Gejl M; Steffensen C; Stecher CW; Smidt K; Brock B; Rungby J
    Expert Opin Ther Targets; 2011 Oct; 15(10):1153-62. PubMed ID: 21749267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease: a general introduction and pathomechanism.
    Finder VH
    J Alzheimers Dis; 2010; 22 Suppl 3():5-19. PubMed ID: 20858960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease.
    Nesi G; Sestito S; Digiacomo M; Rapposelli S
    Curr Top Med Chem; 2017; 17(27):3062-3079. PubMed ID: 28595557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glucagon-like peptide 1: a novel therapeutic strategy for Alzheimer's disease].
    Wang XH; Yang W; Qi JS
    Sheng Li Xue Bao; 2010 Oct; 62(5):398-406. PubMed ID: 20945041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Molecule Natural Products and Alzheimer's Disease.
    Wu X; Cai H; Pan L; Cui G; Qin F; Li Y; Cai Z
    Curr Top Med Chem; 2019; 19(3):187-204. PubMed ID: 30714527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease.
    El Gaamouch F; Liu K; Lin HY; Wu C; Wang J
    Neurochem Int; 2021 Jul; 147():105046. PubMed ID: 33872681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.